AACR releases large cancer genomic data set from project GENIE
نویسندگان
چکیده
منابع مشابه
AACR Project GENIE: Powering Precision Medicine through an International Consortium.
The AACR Project GENIE is an international data-sharing consortium focused on generating an evidence base for precision cancer medicine by integrating clinical-grade cancer genomic data with clinical outcome data for tens of thousands of cancer patients treated at multiple institutions worldwide. In conjunction with the first public data release from approximately 19,000 samples, we describe th...
متن کاملExploring cancer genomic data from the cancer genome atlas project
The Cancer Genome Atlas (TCGA) has compiled genomic, epigenomic, and proteomic data from more than 10,000 samples derived from 33 types of cancer, aiming to improve our understanding of the molecular basis of cancer development. Availability of these genome-wide information provides an unprecedented opportunity for uncovering new key regulators of signaling pathways or new roles of pre-existing...
متن کاملPredicting Kidney Cancer Survival from Genomic Data
Cancers are on par with heart disease as the leading cause for mortality in the United States. In particular, Kidney Renal Clear Cell Carcinoma (KIRC) has an approximate five-year mortality rate of 53%. Cancer mortality, however, is highly variable, and the side effects of current standard of care treatment regimens are severe and costly. Survival indications and the course of action pursued ar...
متن کاملMultidimensional Gene Set Analysis of Genomic Data
Understanding the functional implications of changes in gene expression, mutations, etc., is the aim of most genomic experiments. To achieve this, several functional profiling methods have been proposed. Such methods study the behaviour of different gene modules (e.g. gene ontology terms) in response to one particular variable (e.g. differential gene expression). In spite to the wealth of infor...
متن کاملOptimal Tabular Releases from Confidential Data
We describe and illustrate NISS-developed optimal tabular release technology, which releases sets of sub-tables of large contingency tables that maximize data utility (in our examples, the number of sub-tables released) subject to a constraint on disclosure risk (tightness of bounds on small-count, risky cells in the underlying table). This approach explicitly accommodates the mandate of Federa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2017
ISSN: 0008-543X
DOI: 10.1002/cncr.30755